Diurnal IOP-lowering efficacy and safety of travoprost 0.004% compared with tafluprost 0.0015% in patients with primary open-angle glaucoma or ocular hypertension

PURPOSE: To compare the diurnal intraocular pressure (IOP)-lowering efficacy and safety of travoprost 0.004% and tafluprost 0.0015% administered to patients with primary open-angle glaucoma or ocular hypertension. METHODS: This was a randomized, double-masked, active-controlled, crossover design tri...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Schnober, Dietmar, Hofmann, Günter, Maier, Hubert, Scherzer, Maria-Luise, Ogundele, Abayomi B, Jasek, Mark C
Format: Artigo
Langue:Inglês
Publié: Dove Medical Press 2010
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3009992/
https://ncbi.nlm.nih.gov/pubmed/21191441
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S13720
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires